The effect of addition of liraglutide to high-dose intensive insulin therapy: a randomized prospective trial
Author:
Affiliation:
1. Mountain Diabetes and Endocrine Center; Asheville NC USA
Funder
Novo Nordisk
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12286/fullpdf
Reference17 articles.
1. Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized controlled trial;Buse;Ann Intern Med,2011
2. Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes;Vora;Diabetes Metab,2013
3. Medical care for patients with diabetes - epidemiologic aspects;Harris;Ann Intern Med,1996
4. Incretin-based therapies for type 2 diabetes mellitus;Lovshin;Nat Rev Endocrinol,2009
5. Glucagon-like peptide-1 analog and insulin combination therapy in the management of adults with type 2 diabetes mellitus;Tzefos;Ann Pharmacother,2012
Cited by 68 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus;Endocrinología, Diabetes y Nutrición;2024-08
2. Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial;Frontiers in Pharmacology;2023-05-04
3. Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study;Diabetology International;2022-07-13
4. The Effects of Adding Semaglutide to High Daily Dose Insulin Regimens in Patients With Type 2 Diabetes;Annals of Pharmacotherapy;2022-07-01
5. An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis;Renal Replacement Therapy;2022-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3